AAAAAA
Results:
1-15
|
Results: 15
Authors:
EVENRAM S
UZIELY B
COHEN P
GRISARUGRANOVSKY S
MAOZ M
GINZBURG Y
REICH R
VLODAVSKY I
BARSHAVIT R
Citation: S. Evenram et al., THROMBIN RECEPTOR OVEREXPRESSION IN MALIGNANT AND PHYSIOLOGICAL INVASION PROCESSES, Nature medicine, 4(8), 1998, pp. 909-914
Authors:
MUGGIA FM
HAINSWORTH JD
JEFFERS S
MILLER P
GROSHEN S
TAN M
ROMAN L
UZIELY B
MUDERSPACH L
GARCIA A
BURNETT A
GRECO FA
MORROW CP
PARADISO LJ
LIANG LJ
Citation: Fm. Muggia et al., PHASE-II STUDY OF LIPOSOMAL DOXORUBICIN IN REFRACTORY OVARIAN-CANCER - ANTITUMOR-ACTIVITY AND TOXICITY MODIFICATION BY LIPOSOMAL ENCAPSULATION, Journal of clinical oncology, 15(3), 1997, pp. 987-993
Authors:
BAIDER L
PERRY S
SISON A
HOLLAND J
UZIELY B
DENOUR AK
Citation: L. Baider et al., THE ROLE OF PSYCHOLOGICAL VARIABLES IN A GROUP OF MELANOMA PATIENTS -AN ISRAELI SAMPLE, Psychosomatics, 38(1), 1997, pp. 45-53
Authors:
SHUSHAN A
PERETZ T
UZIELY B
LEWIN A
MORYOSEF S
Citation: A. Shushan et al., OVARIAN CYSTS IN PREMENOPAUSAL AND POSTMENOPAUSAL TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER, American journal of obstetrics and gynecology, 174(1), 1996, pp. 141-144
Authors:
UZIELY B
JEFFERS S
ISACSON R
KUTSCH K
WEITSAO D
YEHOSHUA Z
LIBSON E
MUGGIA FM
GABIZON A
Citation: B. Uziely et al., LIPOSOMAL DOXORUBICIN - ANTITUMOR-ACTIVITY AND UNIQUE TOXICITIES DURING 2 COMPLEMENTARY PHASE-I STUDIES, Journal of clinical oncology, 13(7), 1995, pp. 1777-1785
Authors:
UZIELY B
GROSHEN S
JEFFERS S
MORRIS M
RUSSELL C
ROMAN L
MUDERSPACH L
MUGGIA F
Citation: B. Uziely et al., PACLITAXEL (TAXOL) IN HEAVILY PRETREATED OVARIAN-CANCER - ANTITUMOR-ACTIVITY AND COMPLICATIONS, Annals of oncology, 5(9), 1994, pp. 827-833
Authors:
UZIELY B
JEFFERS S
MUGGIA F
Citation: B. Uziely et al., LOW-DOSES OF DEXAMETHASONE PROTECT AGAINST PACLITAXEL (TAXOL)-RELATEDHYPERSENSITIVITY REACTIONS FOLLOWING CYCLE-1, Annals of oncology, 5(5), 1994, pp. 474-474
Authors:
UZIELY B
FORMENTI SC
WATKINS K
MAZUMDER A
MUGGIA FM
Citation: B. Uziely et al., CALVERTS FORMULA AND HIGH-DOSE CARBOPLATIN, Journal of clinical oncology, 12(8), 1994, pp. 1740-1741
Authors:
GABIZON A
ISACSON R
LIBSON E
KAUFMAN B
UZIELY B
CATANE R
BENDOR CG
RABELLO E
CASS Y
PERETZ T
SULKES A
CHISIN R
BARENHOLZ Y
Citation: A. Gabizon et al., CLINICAL-STUDIES OF LIPOSOME-ENCAPSULATED DOXORUBICIN, Acta oncologica, 33(7), 1994, pp. 779-786
Authors:
BAIDER L
UZIELY B
DENOUR AK
Citation: L. Baider et al., PROGRESSIVE MUSCLE-RELAXATION AND GUIDED IMAGERY IN CANCER-PATIENTS, General hospital psychiatry, 16(5), 1994, pp. 340-347
Authors:
GABIZON A
CATANE R
UZIELY B
KAUFMAN B
SAFRA T
COHEN R
MARTIN F
HUANG A
BARENHOLZ Y
Citation: A. Gabizon et al., PROLONGED CIRCULATION TIME AND ENHANCED ACCUMULATION IN MALIGNANT EXUDATES OF DOXORUBICIN ENCAPSULATED IN POLYETHYLENE-GLYCOL COATED LIPOSOMES, Cancer research, 54(4), 1994, pp. 987-992
Authors:
ISACSON R
SAFRA T
BENDOR CG
UZIELY B
BRUFMAN G
Citation: R. Isacson et al., A PRELIMINARY-REPORT OF A PILOT RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL WITH CYCLOPHOSPHAMIDE, MITOXANTRONE AND 5-FLUOROURACIL IN THE ADJUVANT THERAPY OF STAGE-II BREAST-CANCER WITH 4 OR MORE POSITIVE AXILLARY NODES, Anti-cancer drugs, 4(2), 1993, pp. 189-192
Authors:
DELAFLORWEISS E
UZIELY B
MUGGIA FM
Citation: E. Delaflorweiss et al., PROTRACTED DRUG INFUSIONS IN CANCER-TREATMENT - AN APPRAISAL OF 5-FLUOROURACIL, DOXORUBICIN, AND PLATINUMS, Annals of oncology, 4(9), 1993, pp. 723-733
Authors:
DRAKOS P
UZIELY B
NAGLER A
GILLIS S
ELDOR A
Citation: P. Drakos et al., SUCCESSFUL ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND COUMARIN-INDUCED SKIN NECROSIS, Haemostasis, 23(5), 1993, pp. 259-262
Authors:
UZIELY B
LEWIN A
BRUFMAN G
DOREMBUS D
MORYOSEF S
Citation: B. Uziely et al., THE EFFECT OF TAMOXIFEN ON THE ENDOMETRIUM, Breast cancer research and treatment, 26(1), 1993, pp. 101-105
Risultati:
1-15
|